Literature DB >> 23827156

Effects of estrogen on CD4(+) CD25(+) regulatory T cell in peripheral blood during pregnancy.

Yuan-Huan Xiong1, Zhen Yuan, Li He.   

Abstract

OBJECTIVE: To investigate the effects of estrogen (E2) level on regulatory T cells (Treg) in peripheral blood during pregnancy.
METHODS: A total of 30 healthy non-pregnant women were selected as control group, 90 pregnant women of early, middle and late pregnancy and 30 postpartum women at 1 month after parturition were selected as experimental groups including early pregnancy group, middle pregnancy group and late pregnancy group; the proportions of CD4(+)CD25(+) Treg and CD4(+)CD25(+)CD127(-) Treg among CD4(+)T cells were detected by flow cytometry; the serum estrogen content in peripheral blood was detected by electrochemical immune luminescence method.
RESULTS: E2 level was coincident with the change of Tregs number during pregnancy. The estrogen content in peripheral blood increased gradually from early pregnancy to late pregnancy, then decreased significantly after parturition, and the level at 1 month after parturition down to the level in non- pregnancy group (P>0.05); the level of E2 in pregnancy groups were significantly higher than those in non- pregnancy group (P<0.01); and there were significant differences among early pregnancy group, middle pregnancy group and late pregnancy group (P<0.05). The proportions of CD4(+) CD25(+) Treg and CD4(+) CD25(+) CD127(-) Treg in pregnancy groups were significantly higher than those in non- pregnancy group (P<0.05), but decreased significantly after parturition, and there was no significant difference between non- pregnancy group and postpartum women group (P>0.05); the proportions in middle and late pregnancy groups were significantly higher than those in early pregnancy group (P<0.05), but decreased slightly in late pregnancy group, there was no significant difference between late pregnancy group and middle pregnancy group (P>0.05). There was correlation between Tregs number with estrogen level during pregnancy. The proportion of CD4(+) CD25(+) Treg and CD4(+) CD25(+) CD127(-) Treg were positively correlated with estrogen level.
CONCLUSIONS: High proportion of CD4(+) CD25(+) Treg and CD4(+)CD25(+)CD127(-) Treg is closely related to the high level of E2 during pregnancy. It suggested that high level of estrogen may induce an increase of CD4(+) CD25(+) Treg in peripheral blood, and then influence the immune function of pregnant women. The results of this experiment might play an important role of estrogen in immune-modulation during pregnancy.
Copyright © 2013 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD4(+) CD25(+) CD127- regulatory T cell; CD4(+) CD25(+) regulatory T cell; Estrogen; Immuno-modulation; Pregnancy

Mesh:

Substances:

Year:  2013        PMID: 23827156     DOI: 10.1016/S1995-7645(13)60131-5

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  12 in total

Review 1.  Oversight and Management of Women with Psoriasis in Childbearing Age.

Authors:  Ștefana Bucur; Alexandra-Petruța Savu; Ana Maria Alexandra Stănescu; Elena-Daniela Șerban; Alin-Codruț Nicolescu; Traian Constantin; Anca Bobircă; Maria-Magdalena Constantin
Journal:  Medicina (Kaunas)       Date:  2022-06-09       Impact factor: 2.948

Review 2.  Psoriasis: female skin changes in various hormonal stages throughout life--puberty, pregnancy, and menopause.

Authors:  Romana Ceovic; Marko Mance; Zrinka Bukvic Mokos; Maja Svetec; Kresimir Kostovic; Daska Stulhofer Buzina
Journal:  Biomed Res Int       Date:  2013-12-28       Impact factor: 3.411

Review 3.  Endocrine factors modulating immune responses in pregnancy.

Authors:  Anne Schumacher; Serban-Dan Costa; Ana Claudia Zenclussen
Journal:  Front Immunol       Date:  2014-05-08       Impact factor: 7.561

4.  Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.

Authors:  Kerstin Weitmann; Carsten Hirt; Sabine Schwarz; Charles Rabkin; Gottfried Dölken; Wolfgang Hoffmann
Journal:  Cancer Causes Control       Date:  2015-01-30       Impact factor: 2.506

5.  Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration.

Authors:  Kyuichi Kadota; Takashi Eguchi; Jonathan Villena-Vargas; Kaitlin M Woo; Camelia S Sima; David R Jones; William D Travis; Prasad S Adusumilli
Journal:  Oncotarget       Date:  2015-09-29

6.  Contribution of regulatory T cells to immune tolerance and association of microRNA‑210 and Foxp3 in preeclampsia.

Authors:  Jiying Chen; Lijian Zhao; Dengchuan Wang; Yanbin Xu; Haijie Gao; Wenqing Tan; Chenhong Wang
Journal:  Mol Med Rep       Date:  2018-12-10       Impact factor: 2.952

7.  Pruritus after continuous administration of epidural morphine for post-cesarean delivery analgesia: a case control study.

Authors:  Xinyi Tian; Kaifan Niu; Hong Cao; Gonghao Zhan; Yan Zhang; Feng Xu; Wangning Shangguan; Ye Gao
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-15       Impact factor: 3.007

Review 8.  Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies.

Authors:  Soura Chakraborty; Jhuma Pramanik; Bidesh Mahata
Journal:  Genes Immun       Date:  2021-06-14       Impact factor: 2.676

Review 9.  The Endocrine Milieu and CD4 T-Lymphocyte Polarization during Pregnancy.

Authors:  Barbara Polese; Virginie Gridelet; Eleni Araklioti; Henri Martens; Sophie Perrier d'Hauterive; Vincent Geenen
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-07       Impact factor: 5.555

10.  Prevalence of Autoimmune Disease in Patients with Eosinophilic Esophagitis: A Cross-sectional Study of Three Hospitals in Japan.

Authors:  Maki Ayaki; Noriaki Manabe; Minoru Fujita; Ryo Katsumata; Jun Nakamura; Tomoari Kamada; Masayuki Murota; Kazuhiko Inoue; Ken Haruma
Journal:  Intern Med       Date:  2021-05-22       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.